Passive Biotech Equities

iShares Biotechnology ETF

The iShares Biotechnology ETF (the “Fund”) seeks to track the investment results of an index composed of U.S.-listed equities in the biotechnology sector.

$135.70

+5.1% last 12 months

Compare similar ETFs

Fund Size
Dividend
Fees
Current
Biotechnology ETF IBB
Fund Size
$8.53 Billion
Dividend
0.3%
Fees
0.44%
Total Stock Market Index Fund VTI
Fund Size
$1.6 Trillion
Dividend
1.3%
Fees
0.03%
500 Index Fund VOO
Fund Size
$1.11 Trillion
Dividend
1.3%
Fees
0.03%
Core S&P 500 ETF IVV
Fund Size
$456 Billion
Dividend
1.3%
Fees
0.03%
Total International Stock Index Fund VXUS
Fund Size
$404 Billion
Dividend
3.2%
Fees
0.07%
View 1295 similar ETFs →

Average metrics of all companies in portfolio

Compare to
Market
Market Cap The market value of the company. It's calculated by multiplying the share price by the number of outstanding shares. $50.2 Billion
Dividend Yield Yearly payout to shareholders per share. The percentage indicates the payout in relation to the share price. 0.62 %
Beta Indicates the relationship between the price performance of a share and the market. 0.8649
P/E Ratio Ratio between share price and earnings per share. A low ratio could indicate that the stock is undervalued or investors aren't expecting high growth. A high ratio could indicate that the stock is overvalued or investors are expecting high growth. 94.68
Negative P/E Ratio a negative P/E ratio shows that the company is not profitable, and it shows how many years it would take the company to lose its entire market capitalisation if it did not change anything -22.58
Profitable Companies 61
PEG The ratio between the P/E ratio and the growth rate of the company's earnings per share in the last twelve months. A lower PEG could mean that a stock is undervalued. 298.58
Price to Sales Ratio Market cap divided by the revenue in the most recent year. 7.74
Price to Book Ratio Price to Book Ratio is the Market cap divided by the Book value of the company 0.45
Compare to
Market
Enterprise Value to EBIT Enterprise Value divided by EBIT -8.72
Enterprise Value to Revenue Enterprise value divided by revenue 148.22
Total Debt to Enterprise Value Total debt divided by enterprise value 0.12
Debt to Equity A higher ratio indicates a higher risk. However, the ratio is difficult to compare between industries where common amounts of debt vary. 1.1587
Profit Margin Net income divided by revenue of the last 4 quarters. It indicates the company's profitability. -1574.98%
Quarterly Earnings Growth (YoY) The rate at which the company's net income has increased to the same quarter one year ago. -
Return on Equity Equity divided by market cap. -5.98%
Return on Assets Indicates a company's profitability in relation to its total assets. -1.77%
Return on Invested Capital Return on invested capital (ROIC) is net income after dividends divided by the sum of debt and equity. It shows how effective a company is at turning capital invested by shareholders and other debtholders into profits. 1.79%

Industries

Healthcare 87.0%
Other 5.8%
Materials 0.4%
N/A 6.7%

Market cap

Micro Cap 1%
Small Cap 8%
Mid Cap 21%
Large Cap 70%
Mega Cap 0%

223 Investments

P/E-Ratio
Total Investment
Weight
BlackRock Funds III logo

BlackRock Funds III

P/E-Ratio
n/a
Total Investment
$870 Million
Weight
11.4%
Amgen, Inc. logo

AMGN - Manufacturing

Amgen, Inc.

P/E-Ratio
42.6
Total Investment
$641 Million
Weight
8.4%
Gilead Sciences, Inc. logo

GILD - Manufacturing

Gilead Sciences, Inc.

P/E-Ratio
163.6
Total Investment
$627 Million
Weight
8.2%
Regeneron Pharmaceuticals, Inc. logo

REGN - Manufacturing

Regeneron Pharmaceuticals, Inc.

P/E-Ratio
28.7
Total Investment
$615 Million
Weight
8.1%
Vertex Pharmaceuticals, Inc. logo

VRTX - Manufacturing

Vertex Pharmaceuticals, Inc.

P/E-Ratio
30.8
Total Investment
$614 Million
Weight
8.0%
IQVIA Holdings, Inc. logo

IQV - Health Care and Social Assistance

IQVIA Holdings, Inc.

P/E-Ratio
28.7
Total Investment
$341 Million
Weight
4.5%
Moderna, Inc. logo

MRNA - Manufacturing

Moderna, Inc.

P/E-Ratio
-9.3
Total Investment
$269 Million
Weight
3.5%
Biogen, Inc. logo

BIIB - Manufacturing

Biogen, Inc.

P/E-Ratio
29.2
Total Investment
$234 Million
Weight
3.1%
Mettler-Toledo International, Inc. logo

MTD - Manufacturing

Mettler-Toledo International, Inc.

P/E-Ratio
39.9
Total Investment
$212 Million
Weight
2.8%
Illumina, Inc. logo

ILMN - Manufacturing

Illumina, Inc.

P/E-Ratio
-13.5
Total Investment
$163 Million
Weight
2.1%
Waters Corp. logo

WAT - Manufacturing

Waters Corp.

P/E-Ratio
29.0
Total Investment
$153 Million
Weight
2.0%
Argenx SE logo

ARGX - Manufacturing

Argenx SE

P/E-Ratio
0.0
Total Investment
$148 Million
Weight
1.9%
BioNTech SE logo

BNTX - Manufacturing

BioNTech SE

P/E-Ratio
162.3
Total Investment
$143 Million
Weight
1.9%
Alnylam Pharmaceuticals, Inc. logo

ALNY - Manufacturing

Alnylam Pharmaceuticals, Inc.

P/E-Ratio
-61.0
Total Investment
$141 Million
Weight
1.8%
Genmab A/S logo

GMAB - Professional, Scientific, and Technical Services

Genmab A/S

P/E-Ratio
0.0
Total Investment
$126 Million
Weight
1.7%
BioMarin Pharmaceutical, Inc. logo

BMRN - Manufacturing

BioMarin Pharmaceutical, Inc.

P/E-Ratio
77.9
Total Investment
$121 Million
Weight
1.6%
Charles River Laboratories International, Inc. logo

CRL - Professional, Scientific, and Technical Services

Charles River Laboratories International, Inc.

P/E-Ratio
24.6
Total Investment
$102 Million
Weight
1.3%
Neurocrine Biosciences, Inc. logo

NBIX - Manufacturing

Neurocrine Biosciences, Inc.

P/E-Ratio
37.1
Total Investment
$100 Million
Weight
1.3%
Incyte Corp. logo

INCY - Professional, Scientific, and Technical Services

Incyte Corp.

P/E-Ratio
18.9
Total Investment
$95 Million
Weight
1.2%
BeiGene Ltd. logo

BGNE - Manufacturing

BeiGene Ltd.

P/E-Ratio
-20.3
Total Investment
$94.6 Million
Weight
1.2%
Sarepta Therapeutics, Inc. logo

SRPT - Manufacturing

Sarepta Therapeutics, Inc.

P/E-Ratio
699.3
Total Investment
$85.9 Million
Weight
1.1%
Bio-Techne Corp. logo

TECH - Manufacturing

Bio-Techne Corp.

P/E-Ratio
59.7
Total Investment
$82.3 Million
Weight
1.1%
Natera, Inc. logo

NTRA - Health Care and Social Assistance

Natera, Inc.

P/E-Ratio
-31.3
Total Investment
$76 Million
Weight
1.0%
Medpace Holdings, Inc. logo

MEDP - Professional, Scientific, and Technical Services

Medpace Holdings, Inc.

P/E-Ratio
39.1
Total Investment
$74.9 Million
Weight
1.0%
United Therapeutics Corp. logo

UTHR - Manufacturing

United Therapeutics Corp.

P/E-Ratio
12.1
Total Investment
$74.9 Million
Weight
1.0%